3-Bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidine

Catalog No. :
ACRYWP965
CAS No. :
90914-41-3
Molecular Formula :
C5H2BrClN4
Molecular Weight :
233.46

IUPAC Name:3-bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidine

3-Bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g95%$78.00Login to see priceIn stockInquiry
25g95%$159.00Login to see priceIn stockInquiry
100g95%$605.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidine
IUPAC Name3-bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidine
MDL No.MFCD08276165
Molecular FormulaC5H2BrClN4
Molecular Weight233.46
SMILESClC1=C2C(NN=C2Br)=NC=N1
InChI KeyMDFHFCAMBZNSLV-UHFFFAOYSA-N
SynonymMDFHFCAMBZNSLV-UHFFFAOYSA-N | CS-W003500 | Z1139751358 | SCHEMBL473315 | J-511910 | NSC-370382 | EN300-90210 | 3-Bromo-4-chloro-1H-pyrazolo[3,4-d]pyrimidine | STL556979 | SY007219 | AM804534 | BBL103169 | NSC370382 | DTXSID40321105 | MFCD08276165 | MF-073
CAS No.90914-41-3
PubChem CID340228

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRYWP965 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTYHX731 route compound structure diagram
    ACTYHX7315399-92-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRYWP965 route product structure diagram
    ACRYWP96590914-41-3 In Stock
Inquiry

2. ACRYWP965 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYCQO541 route compound structure diagram
    ACYCQO54154738-73-7 In Stock
  4. Then
  5. ACRYWP965 route product structure diagram
    ACRYWP96590914-41-3 In Stock
Inquiry

Comments (0)